25 XP   0   0   10

Prime Medicine Inc. Common Stock
Buy, Hold or Sell?

Let's analyze Prime Medicine Inc. Common Stock together

I guess you are interested in Prime Medicine Inc. Common Stock. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Prime Medicine Inc. Common Stock. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Prime Medicine Inc. Common Stock

I send you an email if I find something interesting about Prime Medicine Inc. Common Stock.

Quick analysis of Prime Medicine Inc. Common Stock (30 sec.)










What can you expect buying and holding a share of Prime Medicine Inc. Common Stock? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$2.03
Expected worth in 1 year
$1.74
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
$-0.29
Return On Investment
-5.5%

For what price can you sell your share?

Current Price per Share
$5.34
Expected price per share
$4.11 - $9.77
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

1. Valuation of Prime Medicine Inc. Common Stock (5 min.)




Live pricePrice per Share (EOD)

$5.34

2. Growth of Prime Medicine Inc. Common Stock (5 min.)




Is Prime Medicine Inc. Common Stock growing?

Current yearPrevious yearGrowGrow %
How rich?$243.7m$163m$39.6m19.6%

How much money is Prime Medicine Inc. Common Stock making?

Current yearPrevious yearGrowGrow %
Making money-$51.1m-$34.3m-$16.7m-32.8%
Net Profit Margin-1,999.6%-188.5%--

How much money comes from the company's main activities?

3. Financial Health of Prime Medicine Inc. Common Stock (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

What can you expect buying and holding a share of Prime Medicine Inc. Common Stock? (5 min.)

Welcome investor! Prime Medicine Inc. Common Stock's management wants to use your money to grow the business. In return you get a share of Prime Medicine Inc. Common Stock.

What can you expect buying and holding a share of Prime Medicine Inc. Common Stock?

First you should know what it really means to hold a share of Prime Medicine Inc. Common Stock. And how you can make/lose money.

Speculation

The Price per Share of Prime Medicine Inc. Common Stock is $5.34. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Prime Medicine Inc. Common Stock.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Prime Medicine Inc. Common Stock, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.03. Based on the TTM, the Book Value Change Per Share is $-0.07 per quarter. Based on the YOY, the Book Value Change Per Share is $0.08 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Prime Medicine Inc. Common Stock.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.38-7.1%-0.43-8.0%-0.32-5.9%-0.38-7.1%-0.38-7.1%
Usd Book Value Change Per Share0.9217.3%-0.07-1.4%0.081.5%0.203.8%0.203.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.9217.3%-0.07-1.4%0.081.5%0.203.8%0.203.8%
Usd Price Per Share7.00-10.01-7.72-7.09-7.09-
Price to Earnings Ratio-4.59--6.16--5.78--4.78--4.78-
Price-to-Total Gains Ratio7.59--20.03--3.81--14.62--14.62-
Price to Book Ratio3.45-6.17-1.32-3.00-3.00-
Price-to-Total Gains Ratio7.59--20.03--3.81--14.62--14.62-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share5.34
Number of shares187
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.070.20
Usd Total Gains Per Share-0.070.20
Gains per Quarter (187 shares)-13.6537.98
Gains per Year (187 shares)-54.58151.91
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-55-650152142
20-109-1200304294
30-164-1750456446
40-218-2300608598
50-273-2850760750
60-327-3400911902
70-382-395010631054
80-437-450012151206
90-491-505013671358
100-546-560015191510

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.010.00.00.0%0.010.00.00.0%0.010.00.00.0%0.010.00.00.0%
Book Value Change Per Share1.03.00.025.0%3.06.01.030.0%3.06.01.030.0%3.06.01.030.0%3.06.01.030.0%
Dividend per Share0.00.04.00.0%0.00.010.00.0%0.00.010.00.0%0.00.010.00.0%0.00.010.00.0%
Total Gains per Share1.03.00.025.0%3.06.01.030.0%3.06.01.030.0%3.06.01.030.0%3.06.01.030.0%
3rd party ad coffee SUPPORTERis ad-free.

Fundamentals of Prime Medicine Inc. Common Stock

About Prime Medicine Inc. Common Stock

Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address the spectrum of diseases by deploying gene editing technology. The company offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. It has a research collaboration with Cimeio Therapeutics to develop Prime Edited Shielded-Cell & Immunotherapy Pairs for genetic diseases, acute myeloid leukemia, and myelodysplastic syndrome. The company was incorporated in 2019 and is based in Cambridge, Massachusetts.

Fundamental data was last updated by Penke on 2024-06-24 04:24:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

1.1. Profitability of Prime Medicine Inc. Common Stock.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Prime Medicine Inc. Common Stock earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Prime Medicine Inc. Common Stock to the Biotechnology industry mean.
  • A Net Profit Margin of -7,743.0% means that $-77.43 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Prime Medicine Inc. Common Stock:

  • The MRQ is -7,743.0%. The company is making a huge loss. -2
  • The TTM is -1,999.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-7,743.0%TTM-1,999.6%-5,743.4%
TTM-1,999.6%YOY-188.5%-1,811.1%
TTM-1,999.6%5Y-875.2%-1,124.4%
5Y-875.2%10Y-875.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-7,743.0%-168.0%-7,575.0%
TTM-1,999.6%-209.9%-1,789.7%
YOY-188.5%-242.3%+53.8%
5Y-875.2%-401.7%-473.5%
10Y-875.2%-532.2%-343.0%
1.1.2. Return on Assets

Shows how efficient Prime Medicine Inc. Common Stock is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Prime Medicine Inc. Common Stock to the Biotechnology industry mean.
  • -14.7% Return on Assets means that Prime Medicine Inc. Common Stock generated $-0.15 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Prime Medicine Inc. Common Stock:

  • The MRQ is -14.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -21.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-14.7%TTM-21.2%+6.5%
TTM-21.2%YOY-12.2%-9.0%
TTM-21.2%5Y-16.2%-5.0%
5Y-16.2%10Y-16.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-14.7%-11.9%-2.8%
TTM-21.2%-11.9%-9.3%
YOY-12.2%-11.3%-0.9%
5Y-16.2%-13.5%-2.7%
10Y-16.2%-14.9%-1.3%
1.1.3. Return on Equity

Shows how efficient Prime Medicine Inc. Common Stock is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Prime Medicine Inc. Common Stock to the Biotechnology industry mean.
  • -18.8% Return on Equity means Prime Medicine Inc. Common Stock generated $-0.19 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Prime Medicine Inc. Common Stock:

  • The MRQ is -18.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -28.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-18.8%TTM-28.0%+9.2%
TTM-28.0%YOY-11.4%-16.5%
TTM-28.0%5Y-19.4%-8.6%
5Y-19.4%10Y-19.4%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-18.8%-14.2%-4.6%
TTM-28.0%-15.7%-12.3%
YOY-11.4%-14.3%+2.9%
5Y-19.4%-19.2%-0.2%
10Y-19.4%-19.7%+0.3%
3rd party ad coffee SUPPORTERis ad-free.

1.2. Operating Efficiency of Prime Medicine Inc. Common Stock.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Prime Medicine Inc. Common Stock is operating .

  • Measures how much profit Prime Medicine Inc. Common Stock makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Prime Medicine Inc. Common Stock to the Biotechnology industry mean.
  • An Operating Margin of -8,179.5% means the company generated $-81.80  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Prime Medicine Inc. Common Stock:

  • The MRQ is -8,179.5%. The company is operating very inefficient. -2
  • The TTM is -2,098.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-8,179.5%TTM-2,098.0%-6,081.6%
TTM-2,098.0%YOY-185.6%-1,912.3%
TTM-2,098.0%5Y-913.4%-1,184.5%
5Y-913.4%10Y-913.4%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-8,179.5%-354.6%-7,824.9%
TTM-2,098.0%-225.9%-1,872.1%
YOY-185.6%-252.2%+66.6%
5Y-913.4%-428.3%-485.1%
10Y-913.4%-531.1%-382.3%
1.2.2. Operating Ratio

Measures how efficient Prime Medicine Inc. Common Stock is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 82.80 means that the operating costs are $82.80 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Prime Medicine Inc. Common Stock:

  • The MRQ is 82.795. The company is inefficient in keeping operating costs low. -1
  • The TTM is 21.230. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ82.795TTM21.230+61.566
TTM21.230YOY2.032+19.197
TTM21.2305Y9.305+11.925
5Y9.30510Y9.3050.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ82.7953.004+79.791
TTM21.2303.332+17.898
YOY2.0323.502-1.470
5Y9.3055.271+4.034
10Y9.3056.915+2.390
3rd party ad coffee SUPPORTERis ad-free.

1.3. Liquidity of Prime Medicine Inc. Common Stock.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Prime Medicine Inc. Common Stock is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 8.91 means the company has $8.91 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Prime Medicine Inc. Common Stock:

  • The MRQ is 8.905. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.839. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ8.905TTM5.839+3.066
TTM5.839YOY8.944-3.105
TTM5.8395Y8.024-2.185
5Y8.02410Y8.0240.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.9053.767+5.138
TTM5.8394.000+1.839
YOY8.9444.905+4.039
5Y8.0245.883+2.141
10Y8.0246.286+1.738
1.3.2. Quick Ratio

Measures if Prime Medicine Inc. Common Stock is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Prime Medicine Inc. Common Stock to the Biotechnology industry mean.
  • A Quick Ratio of 13.39 means the company can pay off $13.39 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Prime Medicine Inc. Common Stock:

  • The MRQ is 13.391. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 8.643. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ13.391TTM8.643+4.748
TTM8.643YOY13.237-4.594
TTM8.6435Y9.362-0.719
5Y9.36210Y9.3620.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ13.3913.054+10.337
TTM8.6433.506+5.137
YOY13.2374.756+8.481
5Y9.3625.757+3.605
10Y9.3626.338+3.024
3rd party ad coffee SUPPORTERis ad-free.

1.4. Solvency of Prime Medicine Inc. Common Stock.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Prime Medicine Inc. Common Stock assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Prime Medicine Inc. Common Stock to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.22 means that Prime Medicine Inc. Common Stock assets are financed with 21.7% credit (debt) and the remaining percentage (100% - 21.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Prime Medicine Inc. Common Stock:

  • The MRQ is 0.217. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.216. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.217TTM0.216+0.001
TTM0.216YOY0.377-0.161
TTM0.2165Y0.278-0.062
5Y0.27810Y0.2780.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2170.330-0.113
TTM0.2160.342-0.126
YOY0.3770.287+0.090
5Y0.2780.368-0.090
10Y0.2780.382-0.104
1.4.2. Debt to Equity Ratio

Measures if Prime Medicine Inc. Common Stock is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Prime Medicine Inc. Common Stock to the Biotechnology industry mean.
  • A Debt to Equity ratio of 27.7% means that company has $0.28 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Prime Medicine Inc. Common Stock:

  • The MRQ is 0.277. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.284. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.277TTM0.284-0.007
TTM0.284YOY0.154+0.130
TTM0.2845Y0.227+0.057
5Y0.22710Y0.2270.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2770.365-0.088
TTM0.2840.415-0.131
YOY0.1540.370-0.216
5Y0.2270.443-0.216
10Y0.2270.476-0.249
3rd party ad coffee SUPPORTERis ad-free.

2. Market Valuation of Prime Medicine Inc. Common Stock

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Prime Medicine Inc. Common Stock generates.

  • Above 15 is considered overpriced but always compare Prime Medicine Inc. Common Stock to the Biotechnology industry mean.
  • A PE ratio of -4.59 means the investor is paying $-4.59 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Prime Medicine Inc. Common Stock:

  • The EOD is -3.502. Based on the earnings, the company is expensive. -2
  • The MRQ is -4.590. Based on the earnings, the company is expensive. -2
  • The TTM is -6.164. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.502MRQ-4.590+1.089
MRQ-4.590TTM-6.164+1.574
TTM-6.164YOY-5.776-0.389
TTM-6.1645Y-4.776-1.388
5Y-4.77610Y-4.7760.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.502-2.341-1.161
MRQ-4.590-2.997-1.593
TTM-6.164-2.882-3.282
YOY-5.776-3.553-2.223
5Y-4.776-6.262+1.486
10Y-4.776-6.288+1.512
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Prime Medicine Inc. Common Stock:

  • The EOD is -2.288. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.999. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -6.473. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.288MRQ-2.999+0.711
MRQ-2.999TTM-6.473+3.474
TTM-6.473YOY-6.042-0.431
TTM-6.4735Y-5.006-1.467
5Y-5.00610Y-5.0060.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.288-2.932+0.644
MRQ-2.999-3.739+0.740
TTM-6.473-3.776-2.697
YOY-6.042-4.917-1.125
5Y-5.006-7.942+2.936
10Y-5.006-8.503+3.497
3rd party ad coffee SUPPORTERis ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Prime Medicine Inc. Common Stock is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.45 means the investor is paying $3.45 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Prime Medicine Inc. Common Stock:

  • The EOD is 2.629. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.447. Based on the equity, the company is fair priced.
  • The TTM is 6.167. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD2.629MRQ3.447-0.817
MRQ3.447TTM6.167-2.720
TTM6.167YOY1.324+4.843
TTM6.1675Y2.996+3.170
5Y2.99610Y2.9960.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.6291.843+0.786
MRQ3.4472.249+1.198
TTM6.1672.301+3.866
YOY1.3242.412-1.088
5Y2.9963.782-0.786
10Y2.9964.212-1.216
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Prime Medicine Inc. Common Stock.

3.1. Institutions holding Prime Medicine Inc. Common Stock

Institutions are holding 66.075% of the shares of Prime Medicine Inc. Common Stock.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-31Alphabet Inc12.54894.194415062498320000026.9758
2024-03-31ARK Investment Management LLC4.99320.29055993354285508490.9764
2024-03-31Vanguard Group Inc4.83330.00085801445174653443.0721
2024-03-31FMR Inc3.26950.00183924370-976-0.0249
2024-03-31BlackRock Inc3.12940.00063756210-22408-0.593
2024-03-31Nikko Asset Management Americas Inc2.80320.23363364663-154366-4.3866
2024-03-31Sumitomo Mitsui Trust Holdings Inc2.80320.01623364663-154366-4.3866
2024-03-31T. Rowe Price Investment Management,Inc.2.57440.0132309008330900830
2024-03-31T. Rowe Price Associates, Inc.2.10160.0022252259030143113.5709
2024-03-31Redmile Group, LLC1.72820.533207435075000056.6316
2024-03-31Avidity Partners Management LP1.65790.4491199000019900000
2024-03-31MWG Management Ltd.1.49319.2895179221000
2024-03-31Baker Bros Advisors LP0.85680.0903102846600
2024-03-31Geode Capital Management, LLC0.76390.0006916861293583.3079
2024-03-31Deerfield Management Co0.73760.107888531400
2024-03-31State Street Corporation0.64880.0002778782190242.504
2024-03-31Farallon Capital Management, L.L.C.0.62480.02387500007500000
2024-03-31EcoR1 Capital, LLC0.58320.12397000007000000
2024-03-31Greenwich Wealth Management LLC0.48150.32235780016500012.6705
2024-03-31Samsara BioCapital, LLC0.45010.58515403047000014.884
Total 49.082616.278958914164+15234398+25.9%

3.2. Funds holding Prime Medicine Inc. Common Stock

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-31ARK Genomic Revolution2.51081.31273013770681252.3127
2024-05-31ARK Genomic Revolution ETF2.46821.42882962608-2693-0.0908
2024-05-31ARK Innovation ETF2.2540.2842270544526721910.9596
2024-03-31ARK Disruptive Innovation Full Composite2.18920.2369262766526276650
2024-05-31Vanguard Total Stock Mkt Idx Inv1.80370.0009216497100
2024-05-31Vanguard Small Cap Index1.43780.0078172577840800.237
2024-03-31US Small-Cap Growth II Equity Comp1.35890.0452163113718539112.8232
2024-03-31T. Rowe Price New Horizons1.35890.0452163113718539112.8232
2024-04-30Nikko AM ARK Pstv Chg Innovt P JPY Acc1.22530.3321147072600
2024-04-30Nikko AM ARK Disruptive Innovation A USD1.21570.2756145926700
2024-05-31Vanguard Small Cap Growth Index Inv0.81880.0182982871100261.0306
2024-05-30iShares Russell 2000 ETF0.76630.010191977269960.7665
2024-03-31T. Rowe Price Small-Cap Value0.66790.05228016788016780
2024-03-31T. Rowe Price Small-Cap Stock0.61840.0537423067423060
2024-03-31T. Rowe Price US Small-Cap Core Equity0.61840.0537423067423060
2024-05-31Vanguard Institutional Extnd Mkt Idx Tr0.49470.003859382600
2024-04-30BlackRock Health Sciences Term Trust0.34340.110641213900
2024-03-31Fidelity Small Cap Index0.32820.0103393884-10925-2.6988
2024-03-31T. Rowe Price U.S. SC Value Eq Tr-Z0.32290.05123875793875790
2024-03-31T. Rowe Price U.S. SC Core Eq Tr-Z0.30820.05313699263699260
Total 23.10974.384927738791+6385070+23.0%
3rd party ad coffee SUPPORTERis ad-free.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Prime Medicine Inc. Common Stock compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.922-0.073+108%0.082+1028%0.203+354%0.203+354%
Book Value Per Share--2.0311.689+20%1.358+49%1.618+26%1.618+26%
Current Ratio--8.9055.839+53%8.9440%8.024+11%8.024+11%
Debt To Asset Ratio--0.2170.216+0%0.377-42%0.278-22%0.278-22%
Debt To Equity Ratio--0.2770.284-2%0.154+80%0.227+22%0.227+22%
Dividend Per Share----0%-0%-0%-0%
Eps---0.381-0.426+12%-0.315-17%-0.379-1%-0.379-1%
Free Cash Flow Per Share---0.583-0.418-28%-0.290-50%-0.338-42%-0.338-42%
Free Cash Flow To Equity Per Share--0.727-0.089+112%0.091+697%-0.056+108%-0.056+108%
Gross Profit Margin--1.0291.012+2%1.000+3%1.005+2%1.005+2%
Market Cap640965540.000-31%840217000.0001201810387.500-30%926639320.000-9%851379883.000-1%851379883.000-1%
Net Profit Margin---77.430-19.996-74%-1.885-98%-8.752-89%-8.752-89%
Operating Margin---81.795-20.980-74%-1.856-98%-9.134-89%-9.134-89%
Operating Ratio--82.79521.230+290%2.032+3974%9.305+790%9.305+790%
Pb Ratio2.629-31%3.4476.167-44%1.324+160%2.996+15%2.996+15%
Pe Ratio-3.502+24%-4.590-6.164+34%-5.776+26%-4.776+4%-4.776+4%
Price Per Share5.340-31%7.00010.013-30%7.720-9%7.093-1%7.093-1%
Price To Free Cash Flow Ratio-2.288+24%-2.999-6.473+116%-6.042+101%-5.006+67%-5.006+67%
Price To Total Gains Ratio5.790-31%7.590-20.033+364%-3.809+150%-14.625+293%-14.625+293%
Quick Ratio--13.3918.643+55%13.237+1%9.362+43%9.362+43%
Return On Assets---0.147-0.212+44%-0.122-17%-0.162+11%-0.162+11%
Return On Equity---0.188-0.280+49%-0.114-39%-0.194+3%-0.194+3%
Total Gains Per Share--0.922-0.073+108%0.082+1028%0.203+354%0.203+354%
Usd Book Value--243766000.000202724000.000+20%163060500.000+49%194225800.000+26%194225800.000+26%
Usd Book Value Change Per Share--0.922-0.073+108%0.082+1028%0.203+354%0.203+354%
Usd Book Value Per Share--2.0311.689+20%1.358+49%1.618+26%1.618+26%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.381-0.426+12%-0.315-17%-0.379-1%-0.379-1%
Usd Free Cash Flow---70031000.000-50151750.000-28%-34750250.000-50%-40565800.000-42%-40565800.000-42%
Usd Free Cash Flow Per Share---0.583-0.418-28%-0.290-50%-0.338-42%-0.338-42%
Usd Free Cash Flow To Equity Per Share--0.727-0.089+112%0.091+697%-0.056+108%-0.056+108%
Usd Market Cap640965540.000-31%840217000.0001201810387.500-30%926639320.000-9%851379883.000-1%851379883.000-1%
Usd Price Per Share5.340-31%7.00010.013-30%7.720-9%7.093-1%7.093-1%
Usd Profit---45761000.000-51124250.000+12%-34344500.000-25%-42862600.000-6%-42862600.000-6%
Usd Revenue--591000.0006570750.000-91%1302500.000-55%3149300.000-81%3149300.000-81%
Usd Total Gains Per Share--0.922-0.073+108%0.082+1028%0.203+354%0.203+354%
 EOD+2 -6MRQTTM+21 -13YOY+14 -205Y+17 -1710Y+17 -17

4.2. Fundamental Score

Let's check the fundamental score of Prime Medicine Inc. Common Stock based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.502
Price to Book Ratio (EOD)Between0-12.629
Net Profit Margin (MRQ)Greater than0-77.430
Operating Margin (MRQ)Greater than0-81.795
Quick Ratio (MRQ)Greater than113.391
Current Ratio (MRQ)Greater than18.905
Debt to Asset Ratio (MRQ)Less than10.217
Debt to Equity Ratio (MRQ)Less than10.277
Return on Equity (MRQ)Greater than0.15-0.188
Return on Assets (MRQ)Greater than0.05-0.147
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Prime Medicine Inc. Common Stock based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.151
Ma 20Greater thanMa 506.319
Ma 50Greater thanMa 1006.167
Ma 100Greater thanMa 2006.619
OpenGreater thanClose5.340
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets311,383
Total Liabilities67,617
Total Stockholder Equity243,766
 As reported
Total Liabilities 67,617
Total Stockholder Equity+ 243,766
Total Assets = 311,383

Assets

Total Assets311,383
Total Current Assets217,654
Long-term Assets93,729
Total Current Assets
Cash And Cash Equivalents 94,162
Short-term Investments 116,561
Other Current Assets 6,931
Total Current Assets  (as reported)217,654
Total Current Assets  (calculated)217,654
+/-0
Long-term Assets
Property Plant Equipment 79,454
Long-term Assets Other 779
Long-term Assets  (as reported)93,729
Long-term Assets  (calculated)80,233
+/- 13,496

Liabilities & Shareholders' Equity

Total Current Liabilities24,441
Long-term Liabilities43,176
Total Stockholder Equity243,766
Total Current Liabilities
Short-term Debt 6,751
Accounts payable 10,078
Other Current Liabilities 7,612
Total Current Liabilities  (as reported)24,441
Total Current Liabilities  (calculated)24,441
+/-0
Long-term Liabilities
Capital Lease Obligations 43,793
Long-term Liabilities  (as reported)43,176
Long-term Liabilities  (calculated)43,793
+/- 617
Total Stockholder Equity
Common Stock2
Retained Earnings -537,091
Accumulated Other Comprehensive Income -95
Other Stockholders Equity 780,950
Total Stockholder Equity (as reported)243,766
Total Stockholder Equity (calculated)243,766
+/-0
Other
Capital Stock2
Cash and Short Term Investments 210,723
Common Stock Shares Outstanding 104,466
Liabilities and Stockholders Equity 311,383
Net Debt -50,369
Net Invested Capital 243,766
Net Working Capital 193,213
Property Plant and Equipment Gross 88,253
Short Long Term Debt Total 43,793



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302019-12-31
> Total Assets 
0
0
301,856
0
247,597
215,265
360,314
316,946
280,865
239,145
193,851
311,383
311,383193,851239,145280,865316,946360,314215,265247,5970301,85600
   > Total Current Assets 
0
0
270,579
211,956
181,605
148,845
293,921
249,518
207,618
184,531
142,976
217,654
217,654142,976184,531207,618249,518293,921148,845181,605211,956270,57900
       Cash And Cash Equivalents 
0
0
185,420
0
92,239
47,947
187,620
133,462
120,577
43,959
41,574
94,162
94,16241,57443,959120,577133,462187,62047,94792,2390185,42000
       Short-term Investments 
0
0
84,200
0
88,364
98,718
106,301
116,056
87,041
121,358
80,091
116,561
116,56180,091121,35887,041116,056106,30198,71888,364084,20000
       Net Receivables 
0
0
0
0
0
5,613
0
1,646
1,816
0
0
0
0001,8161,64605,61300000
       Other Current Assets 
0
0
959
0
1,002
11,723
2,697
3,982
10,872
19,214
2,254
6,931
6,9312,25419,21410,8723,9822,69711,7231,002095900
   > Long-term Assets 
0
0
31,277
0
65,992
66,420
66,393
67,428
73,247
54,614
50,875
93,729
93,72950,87554,61473,24767,42866,39366,42065,992031,27700
       Property Plant Equipment 
0
0
15,678
15,666
47,625
47,311
48,554
48,304
47,063
39,302
36,600
79,454
79,45436,60039,30247,06348,30448,55447,31147,62515,66615,67800
       Other Assets 
0
0
15,599
16,929
18,367
19,109
15,142
0
15,312
0
0
0
00015,312015,14219,10918,36716,92915,59900
> Total Liabilities 
0
0
62,296
0
46,860
42,561
360,314
38,145
40,763
45,188
60,780
67,617
67,61760,78045,18840,76338,145360,31442,56146,860062,29600
   > Total Current Liabilities 
0
0
57,983
12,890
23,833
22,218
26,714
23,871
28,722
39,366
56,423
24,441
24,44156,42339,36628,72223,87126,71422,21823,83312,89057,98300
       Short-term Debt 
0
0
7,336
0
11,963
11,577
11,694
11,767
13,509
11,219
9,276
6,751
6,7519,27611,21913,50911,76711,69411,57711,96307,33600
       Accounts payable 
0
0
1,435
3,196
5,885
4,111
4,332
4,561
5,490
14,124
19,537
10,078
10,07819,53714,1245,4904,5614,3324,1115,8853,1961,43500
       Other Current Liabilities 
0
0
12,299
1,084
5,985
6,530
10,688
7,543
806
847
1,605
7,612
7,6121,6058478067,54310,6886,5305,9851,08412,29900
   > Long-term Liabilities 
0
0
4,313
0
23,027
20,343
17,330
14,274
12,041
5,822
4,357
43,176
43,1764,3575,82212,04114,27417,33020,34323,02704,31300
       Warrants
0
0
0
0
0
791,600
0
0
0
0
0
0
000000791,60000000
       Other Liabilities 
0
0
1,243
711
269
481
279
0
108
0
0
0
00010802794812697111,24300
       Deferred Long Term Liability 
0
0
0
0
0
0
0
77
108
0
0
0
000108770000000
> Total Stockholder Equity
0
0
239,560
0
200,737
172,704
-293,581
278,801
240,102
193,957
133,071
243,766
243,766133,071193,957240,102278,801-293,581172,704200,7370239,56000
   Common Stock
0
0
0
1
0
0
2
2
2
2
2
2
222222001000
   Retained Earnings Total Equity000-374,979-332,594-293,197-253,91400000
   Accumulated Other Comprehensive Income -95-15-149-268-205-384-454-1500-2700
   Capital Surplus 
0
0
0
0
0
31,272
609,849
611,598
615,347
0
0
0
000615,347611,598609,84931,27200000
   Treasury Stock000000000000
   Other Stockholders Equity 
0
0
15,163
-32
29,651
31,272
-360,316
611,598
615,347
619,791
624,414
780,950
780,950624,414619,791615,347611,598-360,31631,27229,651-3215,16300



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-4,653
Gross Profit-4,653-4,653
 
Operating Income (+$)
Gross Profit-4,653
Operating Expense-186,639
Operating Income-191,292-191,292
 
Operating Expense (+$)
Research Development147,905
Selling General Administrative43,387
Selling And Marketing Expenses4,653
Operating Expense186,639195,945
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-191,292
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-198,412-184,172
EBIT - interestExpense = -191,292
-198,412
-198,133
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-191,292-198,412
Earnings Before Interest and Taxes (EBITDA)-186,639
 
After tax Income (+$)
Income Before Tax-198,412
Tax Provision--465
Net Income From Continuing Ops-171,773-197,947
Net Income-198,133
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses191,292
Total Other Income/Expenses Net-7,1200
 

Technical Analysis of Prime Medicine Inc. Common Stock
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Prime Medicine Inc. Common Stock. The general trend of Prime Medicine Inc. Common Stock is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Prime Medicine Inc. Common Stock's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Prime Medicine Inc. Common Stock.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 8.1442 < 8.27 < 9.77.

The bearish price targets are: 4.11.

Tweet this
Prime Medicine Inc. Common Stock Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Prime Medicine Inc. Common Stock. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Prime Medicine Inc. Common Stock Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Prime Medicine Inc. Common Stock. The current macd is -0.35784674.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Prime Medicine Inc. Common Stock price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Prime Medicine Inc. Common Stock. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Prime Medicine Inc. Common Stock price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Prime Medicine Inc. Common Stock Daily Moving Average Convergence/Divergence (MACD) ChartPrime Medicine Inc. Common Stock Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Prime Medicine Inc. Common Stock. The current adx is 22.59.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Prime Medicine Inc. Common Stock shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Prime Medicine Inc. Common Stock Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Prime Medicine Inc. Common Stock. The current sar is 6.31795456.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Prime Medicine Inc. Common Stock Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Prime Medicine Inc. Common Stock. The current rsi is 40.15. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Prime Medicine Inc. Common Stock Daily Relative Strength Index (RSI) ChartPrime Medicine Inc. Common Stock Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Prime Medicine Inc. Common Stock. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Prime Medicine Inc. Common Stock price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
Prime Medicine Inc. Common Stock Daily Stochastic Oscillator ChartPrime Medicine Inc. Common Stock Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Prime Medicine Inc. Common Stock. The current cci is -93.99663064.

Prime Medicine Inc. Common Stock Daily Commodity Channel Index (CCI) ChartPrime Medicine Inc. Common Stock Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Prime Medicine Inc. Common Stock. The current cmo is -24.5892698.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Prime Medicine Inc. Common Stock Daily Chande Momentum Oscillator (CMO) ChartPrime Medicine Inc. Common Stock Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Prime Medicine Inc. Common Stock. The current willr is -88.63636364.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Prime Medicine Inc. Common Stock Daily Williams %R ChartPrime Medicine Inc. Common Stock Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Prime Medicine Inc. Common Stock.

Prime Medicine Inc. Common Stock Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Prime Medicine Inc. Common Stock. The current atr is 0.49797463.

Prime Medicine Inc. Common Stock Daily Average True Range (ATR) ChartPrime Medicine Inc. Common Stock Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Prime Medicine Inc. Common Stock. The current obv is -7,072,101.

Prime Medicine Inc. Common Stock Daily On-Balance Volume (OBV) ChartPrime Medicine Inc. Common Stock Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Prime Medicine Inc. Common Stock. The current mfi is 14.26.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Prime Medicine Inc. Common Stock Daily Money Flow Index (MFI) ChartPrime Medicine Inc. Common Stock Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Prime Medicine Inc. Common Stock.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-02-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-27BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-20MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-03BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-17MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-18BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-22MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-29RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-04-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-05-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-05-13WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-20BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-05-21STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-05-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-05-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-05-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-06-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-06-13WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-06-14STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-06-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-06-26BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-03MFI SHORT ENTRY LONG CLOSE20 crossover to downside

6.3. Candlestick Patterns

Prime Medicine Inc. Common Stock Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Prime Medicine Inc. Common Stock based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.151
Ma 20Greater thanMa 506.319
Ma 50Greater thanMa 1006.167
Ma 100Greater thanMa 2006.619
OpenGreater thanClose5.340
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Prime Medicine Inc. Common Stock with someone you think should read this too:
  • Are you bullish or bearish on Prime Medicine Inc. Common Stock? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Prime Medicine Inc. Common Stock? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Prime Medicine Inc. Common Stock

I send you an email if I find something interesting about Prime Medicine Inc. Common Stock.


Stay informed about Prime Medicine Inc. Common Stock.

Receive notifications about Prime Medicine Inc. Common Stock in your mailbox!